Harry Yang

Harry Yang, Ph.D., is Vice President and Head of Biometrics at Fate Therapeutics. He has 27 years of experience across all aspects of drug research and development, from early target discovery, through pre-clinical, clinical, translational science, and CMC programs to regulatory approval and post-approval lifecycle management. He played a pivotal role in the successful submissions of 5 BLAs that ultimately led to marketing approvals of 5 biological products. He has published 8 statistical and data science books, 28 book chapters, over 100 peer-reviewed articles, and 3 industry white papers on diverse scientific, statistical and data science subjects. He is a frequent invited speaker at national and international conferences. He has also developed statistical courses and conducted trainings at the FDA and USP.